Sort
27,075 grants matching “cholesterol”
Intracochlear Electrochemical Gradients
$494,329William E Brownell · Baylor College Of Medicine · R01 · FY2017 · DC
Intracochlear Electrochemical Gradients
$494,329William E Brownell · Baylor College Of Medicine · R01 · FY2018 · DC
Inhalation of Contaminated Mine Waste Dusts as a Route for Systemic Metal Toxicity
$494,241Matthew J Campen · University Of New Mexico Health Scis Ctr · R01 · FY2017 · ES
Effectiveness of Immediate vs. Delayed Use of Metformin in New-Onset T2 Diabetes
$494,231Romain Neugebauer · Kaiser Foundation Research Institute · RC1 · FY2010 · DK
Epidemiology: Oxidative Stress and Early Atherosclerosis
$494,173David R Jacobs · University Of Minnesota · R56 · FY2009 · HL
Roles for Mitochondrial SIRT Deacetylases and Mitochondrial Trafficking in Steroid Hormone Biosynthesis
$494,035Marion B Sewer · Georgia Tech Research Corporation · · FY2008 · BIO
Environmental copper exposure and its impact on microglial Abeta clearance
$493,959Masashi Kitazawa · University Of California-Irvine · R01 · FY2017 · ES
Weight Loss, Inflammation, and Vascular Remodeling
$493,930Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2008 · HL
Project 3: Lipolysis regulation and diabetes-impaired regression
$493,885Ira Jay Goldberg · University Of Washington · P01 · FY2022 · HL
Breast Cancer Prevention by Letrozole in High Risk Women
$493,799Carol J Fabian · University Of Kansas Medical Center · R01 · FY2007 · CA
Project 3: Lipolysis regulation and diabetes-impaired regression
$493,774Ira Jay Goldberg · University Of Washington · P01 · FY2021 · HL
Expression Profiling of Cellular Metabolism Using Massively Parallel Sequencing
$493,756Helen H. Hobbs · Ut Southwestern Medical Center · S10 · FY2010 · RR
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
$493,719Stewart Levine · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Lipid and Protein Effects on Monolayer Stability
$493,705Joseph Anthony Zasadzinski · University Of Minnesota · R01 · FY2023 · HL
A novel role of cholesterol and SR-BI in adipocyte biology
$493,640Chieko Mineo · Ut Southwestern Medical Center · R01 · FY2023 · DK
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis
$493,341Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · R01 · FY2021 · GM
Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)
$493,202Mitchell S Elkind · Columbia University Health Sciences · P50 · FY2011 · NS
Hepatic Lipotoxicity, Metabolic Homeostasis and NAFLD Pathogenesis
$493,050Anna Mae Elizabeth Diehl · Duke University · R56 · FY2023 · DK
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,007Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2010 · HL
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,007Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2011 · HL
GENETIC ANALYSIS OF CVD RISK FACTORS
$493,004Laura A. Almasy · Texas Biomedical Research Institute · P01 · FY2012 · HL
Role of PUFA-Gene Interactions in Health Disparities
$492,933Floyd H Chilton · University Of Arizona · R01 · FY2018 · AT
Genetic Risk Stratification to Identify Individuals for Early Statin Therapy
$492,835Marc S Sabatine · Brigham And Women'S Hospital · RC1 · FY2010 · HL
Structure-Function Relationship Studies of the Plasma Lipid Transfer Proteins CETP and PLTP
$492,699Gang Ren · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2020 · HL
Integrative Genomics of Vanin Gene Expression in Relation to CVD Risk
$492,694Eric Moses · Texas Biomedical Research Institute · R01 · FY2011 · HL